Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1989-02-24
1990-06-12
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530330, A61K 3702, C07K 706
Patent
active
049333232
ABSTRACT:
Novel peptide having the primary structure Asp-Ser-Asp-Gly-Lys or pharmaceutically acceptable salts thereof.
The present peptide possesses activity of inhibiting histamine release and IgE antibody production in the onset of type I-allergy and is effective in the prevention or therapy of type I-allergias such as bronchial asthma, urticaria and allergic rhinitis.
REFERENCES:
patent: 4161522 (1979-07-01), Hamburger
patent: 4171299 (1979-02-01), Hamburger
patent: 4278596 (1981-07-01), Garsky
patent: 4552866 (1985-11-01), Delaney et al.
patent: 4554101 (1985-11-01), Hopp
patent: 4579840 (1986-04-01), Hahn
patent: 4585587 (1986-04-01), Goldberg et al.
patent: 4628045 (1986-12-01), Hahn
Irie Daisuke
Nakajima Bunichiro
Noguchi Keiichi
Hitachi Chemical Co. Ltd.
Lee Lester L.
LandOfFree
Novel peptide and salts thereof and peptide antiallergic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel peptide and salts thereof and peptide antiallergic agents , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel peptide and salts thereof and peptide antiallergic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-617270